Differential response to carfilzomib based on initial therapy with bortezomib in multiple myeloma.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.e19515
Abstract: e19515Background: Proteasome inhibitors (PIs) are efficacious in multiple myeloma (MM). In randomized phase 3 studies Carfilzomib doubled the progression free survival (PFS) compared to Bortezomib ... read more here.
Keywords: initial therapy; response carfilzomib; differential response; multiple myeloma ... See more keywords
Retrospective review for outcomes of IDH mutant, 1p/19q co-deleted gliomas based on initial treatment.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.15_suppl.2063
Abstract: 2063 Background: Treatment for oligodendroglioma in the molecular era is based on trials that used histologic criteria alone and has evolved over time to include observation and a combination of radiation (RT) and chemotherapy. In… read more here.
Keywords: initial treatment; treatment; review outcomes; idh mutant ... See more keywords